Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Induced Pluripotent Stem Cells Reveal Common Neurodevelopmental Genome Deprograming in Schizophrenia.

Narla ST, Decker B, Sarder P, Stachowiak EK, Stachowiak MK.

Results Probl Cell Differ. 2018;66:137-162. doi: 10.1007/978-3-319-93485-3_6.

PMID:
30209658
2.

Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease.

Borroto-Escuela DO, Carlsson J, Ambrogini P, Narváez M, Wydra K, Tarakanov AO, Li X, Millón C, Ferraro L, Cuppini R, Tanganelli S, Liu F, Filip M, Diaz-Cabiale Z, Fuxe K.

Front Cell Neurosci. 2017 Feb 21;11:37. doi: 10.3389/fncel.2017.00037. eCollection 2017. Review.

3.

Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Narla ST, Lee YW, Benson CA, Sarder P, Brennand KJ, Stachowiak EK, Stachowiak MK.

Schizophr Res. 2017 Jul;185:17-32. doi: 10.1016/j.schres.2016.12.012. Epub 2017 Jan 13.

4.

Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related Transcripts.

Weissleder C, Fung SJ, Wong MW, Barry G, Double KL, Halliday GM, Webster MJ, Weickert CS.

Front Aging Neurosci. 2016 Nov 25;8:274. eCollection 2016.

5.

Altered expression of developmental regulators of parvalbumin and somatostatin neurons in the prefrontal cortex in schizophrenia.

Volk DW, Edelson JR, Lewis DA.

Schizophr Res. 2016 Nov;177(1-3):3-9. doi: 10.1016/j.schres.2016.03.001. Epub 2016 Mar 10.

6.

"Nuclear FGF receptor-1 and CREB binding protein: an integrative signaling module".

Stachowiak MK, Birkaya B, Aletta JM, Narla ST, Benson CA, Decker B, Stachowiak EK.

J Cell Physiol. 2015 May;230(5):989-1002. doi: 10.1002/jcp.24879. Review.

PMID:
25503065
7.

The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.

Kucinski A, Wersinger S, Stachowiak EK, Becker C, Lippiello P, Bencherif M, Stachowiak MK.

Behav Pharmacol. 2015 Feb;26(1-2):217-26. doi: 10.1097/FBP.0000000000000122.

PMID:
25485645
8.

Understanding the role of heteroreceptor complexes in the central nervous system.

Fuxe K, Borroto-Escuela D, Fisone G, Agnati LF, Tanganelli S.

Curr Protein Pept Sci. 2014;15(7):647.

PMID:
25256022
9.

MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Mor E, Kano S, Colantuoni C, Sawa A, Navon R, Shomron N.

Neurobiol Dis. 2013 Jul;55:1-10. doi: 10.1016/j.nbd.2013.03.011. Epub 2013 Mar 29.

10.

Fibroblast growth factors in neurodevelopment and psychopathology.

Terwisscha van Scheltinga AF, Bakker SC, Kahn RS, Kas MJ.

Neuroscientist. 2013 Oct;19(5):479-94. doi: 10.1177/1073858412472399. Epub 2013 Jan 23. Review.

PMID:
23343917
11.

Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model.

Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D, Klejbor I, Bencherif M, Birkaya B, Corso T, Parikh A, Tzanakakis ES, Wersinger S, Stachowiak EK.

Schizophr Res. 2013 Feb;143(2-3):367-76. doi: 10.1016/j.schres.2012.11.004. Epub 2012 Dec 8. Review.

PMID:
23231877
12.

α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.

Kucinski A, Syposs C, Wersinger S, Bencherif M, Stachowiak MK, Stachowiak EK.

Schizophr Res. 2012 Apr;136(1-3):82-7. doi: 10.1016/j.schres.2012.01.005. Epub 2012 Jan 30.

PMID:
22285656
13.

β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.

Pedrosa E, Shah A, Tenore C, Capogna M, Villa C, Guo X, Zheng D, Lachman HM.

J Neurogenet. 2010 Dec;24(4):182-93. doi: 10.3109/01677063.2010.495182. Epub 2010 Jul 8.

PMID:
20615089
14.

Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer.

Tabarés-Seisdedos R, Rubenstein JL.

Mol Psychiatry. 2009 Jun;14(6):563-89. doi: 10.1038/mp.2009.2. Epub 2009 Feb 10. Review.

PMID:
19204725
15.
16.

Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains.

Tochigi M, Iwamoto K, Bundo M, Sasaki T, Kato N, Kato T.

Neurosci Res. 2008 Feb;60(2):184-91. Epub 2007 Nov 6.

PMID:
18068248
17.

An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia.

Jungerius BJ, Hoogendoorn ML, Bakker SC, Van't Slot R, Bardoel AF, Ophoff RA, Wijmenga C, Kahn RS, Sinke RJ.

Mol Psychiatry. 2008 Nov;13(11):1060-8. Epub 2007 Sep 25.

PMID:
17893707
18.

Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder.

Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M.

Brain Res Bull. 2006 Jul 31;70(3):221-7. Epub 2006 May 12.

PMID:
16861106
19.

Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.

Klejbor I, Myers JM, Hausknecht K, Corso TD, Gambino AS, Morys J, Maher PA, Hard R, Richards J, Stachowiak EK, Stachowiak MK.

J Neurochem. 2006 Jun;97(5):1243-58. Epub 2006 Mar 8.

Supplemental Content

Loading ...
Support Center